The Clinical Role of Dual-Time-Point 18F-FDG PET/CT in Differential Diagnosis of the Thyroid Incidentaloma

被引:16
|
作者
Lee S. [1 ]
Park T. [1 ]
Park S. [1 ]
Pahk K. [2 ]
Rhee S. [2 ]
Cho J. [2 ]
Jeong E. [2 ]
Kim S. [1 ]
Choe J.G. [2 ]
机构
[1] Departments of Nuclear Medicine, Korea University Guro Hospital, Guro-gu, Seoul, 152-703, # 80, Guro-dong
[2] Departments of Nuclear Medicine, Korea University Anam Hospital, Seoul
关键词
Delay scan; Dual-phase PET; Dual-time-point imaging; Retention index; SUVmax; Thyroid incidentaloma;
D O I
10.1007/s13139-013-0247-z
中图分类号
学科分类号
摘要
Thyroid incidentalomas are common findings during imaging studies including 18F-fluorodeoxyglucose (18F-FDG) positron emission tomography/computed tomography (PET/CT) for cancer evaluation. Although the overall incidence of incidental thyroid uptake detected on PET imaging is low, clinical attention should be warranted owing to the high incidence of harboring primary thyroid malignancy. We retrospectively reviewed 2,368 dual-time-point 18F-FDG PET/CT cases that were undertaken for cancer evaluation from November 2007 to February 2009, to determine the clinical impact of dual-time-point imaging in the differential diagnosis of thyroid incidentalomas. Focal thyroid uptake was identified in 64 PET cases and final diagnosis was clarified with cytology/histology in a total of 27 patients with 18F-FDG-avid incidental thyroid lesion. The maximum standardized uptake value (SUVmax) of the initial image (SUV1) and SUVmax of the delayed image (SUV2) were determined, and the retention index (RI) was calculated by dividing the difference between SUV2 and SUV1 by SUV1 (i.e., RI = [SUV2 - SUV1]/SUV1 × 100). These indices were compared between patient groups that were proven to have pathologically benign or malignant thyroid lesions. There was no statistically significant difference in SUV1 between benign and malignant lesions. SUV2 and RI of the malignant lesions were significantly higher than the benign lesions. The areas under the ROC curves showed that SUV2 and RI have the ability to discriminate between benign and malignant thyroid lesions. The predictability of dual-time-point PET parameters for thyroid malignancy was assessed by ROC curve analyses. When SUV2 of 3.9 was used as cut-off threshold, malignancy on the pathology could be predicted with a sensitivity of 87.5 % and specificity of 75 %. A thyroid lesion that shows RI greater than 12.5 % could be expected to be malignant (sensitivity 88.9 %, specificity 66.3 %). All malignant lesions showed an increase in SUVmax on the delayed images compared with the initial images. But in the group of benign lesions, 37.5 % (6/16) showed a decrease or no change in SUVmax. Dual-time-point 18F-FDG PET/CT, obtaining additional images 2 h after injection, seems to be a complementary method for the differentiation between malignancy and benignity of incidental thyroid lesions. © 2013 Korean Society of Nuclear Medicine.
引用
收藏
页码:121 / 129
页数:8
相关论文
共 50 条
  • [31] SUVmax of 18F-FDG PET/CT in the differential diagnosis of benign and malignant thyroid nodules according to tumor volume
    Tae Heon Kim
    Yong Bae Ji
    Chang Myeon Song
    Ji Young Kim
    Yun Young Choi
    Jeong Seon Park
    Kyung Tae
    World Journal of Surgical Oncology, 13
  • [32] SUVmax of 18F-FDG PET/CT in the differential diagnosis of benign and malignant thyroid nodules according to tumor volume
    Kim, Tae Heon
    Ji, Yong Bae
    Song, Chang Myeon
    Kim, Ji Young
    Choi, Yun Young
    Park, Jeong Seon
    Tae, Kyung
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2015, 13
  • [33] MANAGEMENT PRINCIPLES OF INCIDENTAL THYROID 18F-FDG UPTAKE IDENTIFIED ON 18F-FDG PET/CT IMAGING
    Akbas, A.
    Dagmura, H.
    Gul, S.
    Dasiran, F.
    Daldal, E.
    Okan, I
    ACTA ENDOCRINOLOGICA-BUCHAREST, 2022, 18 (02) : 253 - 257
  • [34] Dual time-point 18F-FDG PET/CT imaging with multiple metabolic parameters in the differential diagnosis of malignancy-suspected bone/joint lesions
    Shen, Chen-Tian
    Qiu, Zhong-Ling
    Sun, Zhen-Kui
    Wei, Wei-Jun
    Song, Hong-Jun
    Zhang, Xin-Yun
    Luo, Quan-Yong
    ONCOTARGET, 2017, 8 (41) : 71188 - 71196
  • [35] Synchronous Thyroid Cancer on the Edge: Incidentalomas of 18F-FDG PET/CT in Clinical Practice
    Ayan, A.
    Basaran, Y.
    Kirnap, N. G.
    Cinar, A.
    NIGERIAN JOURNAL OF CLINICAL PRACTICE, 2021, 24 (06) : 937 - 942
  • [36] Dual-time-point F-18 FDG PET/CT imaging for differentiating the lymph nodes between malignant lymphoma and benign lesions
    Michihiro Nakayama
    Atsutaka Okizaki
    Shunta Ishitoya
    Miki Sakaguchi
    Junichi Sato
    Tamio Aburano
    Annals of Nuclear Medicine, 2013, 27 : 163 - 169
  • [37] Dual-time-point F-18 FDG PET/CT imaging for differentiating the lymph nodes between malignant lymphoma and benign lesions
    Nakayama, Michihiro
    Okizaki, Atsutaka
    Ishitoya, Shunta
    Sakaguchi, Miki
    Sato, Junichi
    Aburano, Tamio
    ANNALS OF NUCLEAR MEDICINE, 2013, 27 (02) : 163 - 169
  • [38] Regional nodal staging with 18F-FDG PET-CT in non-small cell lung cancer: Additional diagnostic value of CT attenuation and dual-time-point imaging
    Li, Meng
    Wu, Ning
    Liu, Ying
    Zheng, Rong
    Liang, Ying
    Zhang, Wenjie
    Zhao, Ping
    EUROPEAN JOURNAL OF RADIOLOGY, 2012, 81 (08) : 1886 - 1890
  • [39] Role of 18F-FDG PET/CT Imaging in Intrahepatic Cholangiocarcinoma
    Jiang, Lei
    Tan, Hui
    Panje, Cedric M.
    Yu, Haojun
    Xiu, Yan
    Shi, Hongcheng
    CLINICAL NUCLEAR MEDICINE, 2016, 41 (01) : 1 - 7
  • [40] Relationship between KRAS mutations and dual time point 18F-FDG PET/CT imaging in colorectal liver metastases
    Wujian Mao
    Jun Zhou
    He Zhang
    Lin Qiu
    Hui Tan
    Yan Hu
    Hongcheng Shi
    Abdominal Radiology, 2019, 44 : 2059 - 2066